1. Home > Latest Topics >

Levofloxacin: a Mainstay of Fluoroquinolone-Based Therapy-After Twenty Years of Use, Levofloxacin Remains Safe and Effective

29 March, 2014

 

Levofloxacin: Maintaining Efficacy in the Treatment of Community-Acquired Pneumonia

 

 


LATEST TOPICS

Managing Infectious Diseases in Emergency Medicine: A Specialist’s Approach
10 April, 2024
Advancing standardised diagnosis and treatment of acute infectious disease: Insights from an expert in theory–technique integration
08 April, 2024
Managing severe infections: Practical approaches for antibiotic use, including combination therapy
05 March, 2024
Updating Traditional Approaches: Expert Insights on Addressing Urinary Tract Infections
26 February, 2024
Antibiotic resistance may be driven by diverse factors, including extreme climatic events
14 February, 2024

RELATED ARTICLES

Levofloxacin in the Treatment of Hospital-Acquired Pneumonia: Insights into Antibiotic Resistance and Tolerance
18 October, 2023
Fluoroquinolones in the management of hospital-acquired pneumonia
20 June, 2023
Community-acquired pneumonia: Insights into the current challenges and the role of levofloxacin
29 January, 2024
Clinical Application of Quinolones in Urology
30 November, 2022
Community-acquired pneumonia: Updates in local treatment strategy and clinical experience with levofloxacin
07 October, 2021